Literature DB >> 21360488

Regulatory natural autoantibodies to apoptotic cells: pallbearers and protectors.

Gregg J Silverman1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21360488      PMCID： PMC3056121          DOI： 10.1002/art.30140

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  26 in total

Review 1.  Tolerogenic dendritic cells.

Authors:  Ralph M Steinman; Daniel Hawiger; Michel C Nussenzweig
Journal:  Annu Rev Immunol       Date:  2001-12-19       Impact factor: 28.527

2.  Natural autoantibodies to apoptotic cell membranes regulate fundamental innate immune functions and suppress inflammation.

Authors:  Gregg J Silverman; Caroline Grönwall; Jaya Vas; Yifang Chen
Journal:  Discov Med       Date:  2009-10       Impact factor: 2.970

3.  Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity.

Authors:  P X Shaw; S Hörkkö; M K Chang; L K Curtiss; W Palinski; G J Silverman; J L Witztum
Journal:  J Clin Invest       Date:  2000-06       Impact factor: 14.808

4.  Autoantibodies to OxLDL fail to alter the clearance of injected OxLDL in apolipoprotein E-deficient mice.

Authors:  Catherine A Reardon; Elizabeth R Miller; Lydia Blachowicz; John Lukens; Christoph J Binder; Joseph L Witztum; Godfrey S Getz
Journal:  J Lipid Res       Date:  2004-04-21       Impact factor: 5.922

5.  Fc gamma RIIa is expressed on natural IFN-alpha-producing cells (plasmacytoid dendritic cells) and is required for the IFN-alpha production induced by apoptotic cells combined with lupus IgG.

Authors:  Ullvi Båve; Mattias Magnusson; Maija-Leena Eloranta; Anders Perers; Gunnar V Alm; Lars Rönnblom
Journal:  J Immunol       Date:  2003-09-15       Impact factor: 5.422

6.  Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL.

Authors:  Christoph J Binder; Sohvi Hörkkö; Asheesh Dewan; Mi-Kyung Chang; Emily P Kieu; Carl S Goodyear; Peter X Shaw; Wulf Palinski; Joseph L Witztum; Gregg J Silverman
Journal:  Nat Med       Date:  2003-05-12       Impact factor: 53.440

7.  The autoreactivity of anti-phosphorylcholine antibodies for atherosclerosis-associated neo-antigens and apoptotic cells.

Authors:  Peter X Shaw; Carl S Goodyear; Mi-Kyung Chang; Joseph L Witztum; Gregg J Silverman
Journal:  J Immunol       Date:  2003-06-15       Impact factor: 5.422

Review 8.  The role of complement in the development of systemic lupus erythematosus.

Authors:  Anthony P Manderson; Marina Botto; Mark J Walport
Journal:  Annu Rev Immunol       Date:  2004       Impact factor: 28.527

9.  Toll-like receptor 9-dependent and -independent dendritic cell activation by chromatin-immunoglobulin G complexes.

Authors:  Melissa W Boulé; Courtney Broughton; Fabienne Mackay; Shizuo Akira; Ann Marshak-Rothstein; Ian R Rifkin
Journal:  J Exp Med       Date:  2004-06-14       Impact factor: 14.307

10.  Complement-dependent clearance of apoptotic cells by human macrophages.

Authors:  D Mevorach; J O Mascarenhas; D Gershov; K B Elkon
Journal:  J Exp Med       Date:  1998-12-21       Impact factor: 14.307
View more
  18 in total

Review 1.  Development of anti-CD20 therapy for multiple sclerosis.

Authors:  Beatrix Bartok; Gregg J Silverman
Journal:  Exp Cell Res       Date:  2011-04-12       Impact factor: 3.905

2.  General Approach for Tetramer-Based Identification of Autoantigen-Reactive B Cells: Characterization of La- and snRNP-Reactive B Cells in Autoimmune BXD2 Mice.

Authors:  Jennie A Hamilton; Jun Li; Qi Wu; PingAr Yang; Bao Luo; Hao Li; John E Bradley; Justin J Taylor; Troy D Randall; John D Mountz; Hui-Chen Hsu
Journal:  J Immunol       Date:  2015-04-17       Impact factor: 5.422

3.  MAPK phosphatase-1 is required for regulatory natural autoantibody-mediated inhibition of TLR responses.

Authors:  Caroline Grönwall; Yifang Chen; Jaya Vas; Sahil Khanna; Steffen Thiel; Maripat Corr; Dwight H Kono; Gregg J Silverman
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-08       Impact factor: 11.205

Review 4.  Protective autoantibodies in the rheumatic diseases: lessons for therapy.

Authors:  Gregg J Silverman; Jaya Vas; Caroline Grönwall
Journal:  Nat Rev Rheumatol       Date:  2013-03-19       Impact factor: 20.543

5.  Antigen-driven induction of polyreactive IgM during intracellular bacterial infection.

Authors:  Derek D Jones; Gregory A DeIulio; Gary M Winslow
Journal:  J Immunol       Date:  2012-06-22       Impact factor: 5.422

6.  RasGRP1 Is an Essential Signaling Molecule for Development of B1a Cells with Autoantigen Receptors.

Authors:  Benchang Guo; Thomas L Rothstein
Journal:  J Immunol       Date:  2016-02-05       Impact factor: 5.422

7.  Natural IgM is produced by CD5- plasma cells that occupy a distinct survival niche in bone marrow.

Authors:  Alexander E Reynolds; Masayuki Kuraoka; Garnett Kelsoe
Journal:  J Immunol       Date:  2014-11-26       Impact factor: 5.422

8.  Human "orchestrator" CD11b(+) B1 cells spontaneously secrete interleukin-10 and regulate T-cell activity.

Authors:  Daniel O Griffin; Thomas L Rothstein
Journal:  Mol Med       Date:  2012-09-07       Impact factor: 6.354

9.  Polyreactive antibodies developing amidst humoral rejection of human kidney grafts bind apoptotic cells and activate complement.

Authors:  F Porcheray; J W Fraser; B Gao; A McColl; J DeVito; I Dargon; Y Helou; W Wong; T C Girouard; S L Saidman; R B Colvin; A Palmisano; U Maggiore; A Vaglio; R N Smith; E Zorn
Journal:  Am J Transplant       Date:  2013-08-06       Impact factor: 8.086

10.  Natural antibody to apoptotic cell membranes inhibits the proinflammatory properties of lupus autoantibody immune complexes.

Authors:  Jaya Vas; Caroline Grönwall; Ann Marshak-Rothstein; Gregg J Silverman
Journal:  Arthritis Rheum       Date:  2012-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.